Analysis

    Anthropic's $81bn IPO: retail investors get access, but how much of the deal did they really get?

    Anthropic priced its Nasdaq listing at $83 on 18 November, and UK investors could apply at the same price as institutions. The UK retail offer came to 3,614,976 shares, about 0.37% of the deal, against orders of nearly $1bn, and applications above £2,171 were scaled back.

    Portrait of Raj PatelRaj PatelHead of Research9 min19 November 2026

    UK investors who applied for Anthropic shares this week paid the same price as institutions. Getting the shares was harder than placing the order.

    Anthropic priced its initial public offering (IPO) at $83 a share on 18 November, above its indicative range of $70 to $78. The offering was 980 million shares: 956.35 million sold by the company and 23.65 million by selling stockholders, among them the seven co-founders. At the offer price that is about $81.34bn in total, of which roughly $79.38bn goes to Anthropic, because the company receives nothing from the shares its existing holders sold. It is the largest base offering on record. SpaceX's June listing raised more in total, $85.7bn, after its underwriters exercised an overallotment option in full; Anthropic's underwriters hold a 30-day option for up to 147 million further shares. The company also placed about $26bn of Class N shares privately with seven technology companies, which takes the combined raise to about $107.3bn. Trading on Nasdaq under the ticker ANT began on 19 November, at a fully diluted valuation of around $1.5tn.

    The UK retail offer accounted for 3,614,976 of those shares, about 0.37%, spread across about 110,000 investors according to the Financial Times. RetailBook, which ran the offer, said about 63% of UK applicants received their full application. Larger applications were scaled back, and RetailBook has not said by how much.

    The UK retail offer: 0.37% of the global deal

    RetailBook is an FCA-authorised public offer platform (POP) operator. It took applications through seven investment platforms: AJ Bell, eToro, Hargreaves Lansdown, Interactive Brokers, interactive investor, Revolut and Robinhood.

    The final allocation was 3,614,976 shares at £63.20 each, the sterling equivalent of $83 at the exchange rate RetailBook used. That comes to about £228.5m. What an applicant receives depends on the currency applied in: investors applying in US dollars apply for the Class A shares themselves, while those applying in pounds sterling apply for CREST depository interests (CDIs), which represent rights to the shares on a one-for-one basis and are a separate instrument under English law, unless their intermediary tells them otherwise.

    RetailBook announced the following allocation policy:

    Application sizeAllocation
    Up to £2,171 ($2,822)Filled in full, rounded down to whole shares
    Above £2,171Scaled back pro rata
    Maximum allocation1,700 shares (£107,440)

    At £63.20 a share, the full-allocation threshold works out at 34 whole shares. An investor who applied for £1,000 received 15 shares and had the balance returned. An investor who applied for £20,000 received only part of that, and the announcement gives neither the scale-back ratio nor a minimum for applications above the threshold. No investor could receive more than 1,700 shares, however much they applied for.

    The outcome is unusual for a heavily oversubscribed deal: most applicants were filled in full, and the cuts fell on the larger applications.

    Demand was roughly three times the allocation. Bloomberg reported that the UK offer drew nearly $1bn of orders, against shares worth about $300m at the offer price. With about 110,000 investors receiving shares, the average allocation works out at roughly $2,700, or 33 shares, just under the full-allocation threshold.

    Hargreaves Lansdown's figures, reported by the FT, show where the cuts fell. Some 45,800 of its clients applied, with an average application of £6,661, and they received about a third of the shares they asked for. Those applications add up to about £305m, more than the £228.5m allocated to the whole UK offer. Of the shares its clients bought, 39% were held in individual savings accounts (ISAs) and a further 31% in self-invested personal pensions (SIPPs).

    The UK also received less than it did from SpaceX. In June, UK investors placed a similar volume of orders, nearly $1bn, and were allocated $364m of SpaceX shares, just under 40% of what they asked for. Anthropic's deal was larger and, according to the FT, drew more UK applicants, yet the UK received about $300m, or roughly 30%.

    The 0.37% figure covers the UK offer only. Anthropic's SEC filings said it expected to allocate up to 20% of the offering to retail investors in the US and other countries.

    How much exposure an allocation buys

    The platforms set their own minimums. Hargreaves Lansdown accepted applications from £250 and AJ Bell from £1,000. At the offer price, £250 buys three shares, an investment of £189.60.

    Rationing is unavoidable when demand exceeds supply, and that is not a flaw in the allocation mechanism. But platforms and issuers increasingly promote access to high-profile listings, and an investor whose application is cut back ends up with far less exposure to the company than they were prepared to pay for.

    The allocation policy was set centrally and based on application size. RetailBook's announcement gives no broker-by-broker breakdown, so there is no published basis for saying that one platform's customers did better than another's. What did differ by platform was the minimum, the deadline and the process, and investors need to keep those separate from the operator's allocation policy.

    Why Anthropic did not price higher

    The final price was 6.4% above the top of the range, and the offering grew from 825 million shares to 980 million. Anthropic raised both the price and the size of the deal as orders came in, and Bloomberg reported before pricing that orders covered the shares as much as six times.

    Issuers and their underwriters have reasons to stop short of the highest price the book would bear. Beyond the price, the company wants a stable shareholder base, long-term holders and a debut that goes well. Large asset managers may own the stock for years, and their presence can steady it after listing. Pricing is also uncertain, and a valuation that turns out too aggressive risks weak demand and a disappointing first day.

    There is a cost. If the shares open well above the IPO price, the difference is money the sellers could have raised and did not. At $83 Anthropic was already above its range, and grey-market prices suggested investors would pay more. Whether the company deliberately left a gain for new shareholders, or the market reassessed the valuation as trading approached, cannot be established from the demand figures.

    The first-day premium and who captures it

    Before the Nasdaq debut, Anthropic-linked perpetual futures on the crypto platform Hyperliquid traded around $100, roughly 20% above the offer price. Bloomberg reported grey-market indications of an opening 20% to 26% above $83: derivatives from the online broker IG International pointed to a market value of about $1.35tn, and the German retail broker Lang & Schwarz quoted shares as high as $105.

    Hyperliquid's perpetual futures are derivatives, not Anthropic shares. They give no ownership, no voting rights and no entitlement to an IPO allocation. They do indicate how much speculative demand surrounds the listing.

    If the market settles well above $83, investors with an allocation start with a paper gain. A 20% rise is worth $16.60 a share before costs and tax. That is about $50 on a three-share allocation, $564 on the 34 shares that mark the full-allocation threshold, and $28,220 on the 1,700-share maximum. For an institution allocated millions of shares the sums are of a different order. Retail investors paid the same price as institutions, but the size of the allocation determines what that is worth.

    An indicated premium is not a guaranteed return. The opening auction sets the first official price, and shares can trade below their IPO price just as easily as above it.

    What happened after SpaceX's first day

    SpaceX's IPO in June is the closest comparison. It was the previous record deal, it had a UK retail offer, and a Hyperliquid contract traded ahead of the debut.

    SpaceX priced at $135, opened at $150 and closed its first day at $160.95, up 19%. The shares touched $225.64 on 16 June, then fell to a closing low of $108.27 on 5 August, the day after the company's first results as a listed business. They closed at $143.50 on 18 November.

    An investor who received SpaceX shares in the IPO and held them is up about 6% after five months. One who bought at the first-day close is down about 11%, and one who bought at the June peak is down 36%.

    The derivatives market overstated the first day. Hyperliquid's SpaceX contract closed the night before listing about 7% above where the shares finished their first session.

    One deal does not predict another. For SpaceX, though, the first-day gain went to those with an allocation, and investors who bought at that day's opening or closing price are below what they paid five months later.

    Selling early: broker flipping policies and insider lock-ups

    Some brokers discourage IPO flipping, the practice of selling an allocation as soon as trading begins to capture the opening premium. Under these policies, selling within a set period can affect a customer's access to later IPOs.

    Interactive Brokers, one of the seven UK platforms, defines flipping as selling within 30 calendar days of allocation and says customers who do so may be limited from taking part in IPOs for 60 days. In the US, E*TRADE says it prefers customers to hold for at least 30 calendar days and reserves the right to exclude from future offerings those who sell or transfer sooner. These are broker policies. They are not imposed by Anthropic or by Nasdaq, and the consequences depend on each broker's terms. RetailBook's results announcement mentions no restriction on when UK investors can sell.

    The lock-ups on Anthropic's existing shareholders are a separate matter. Under the company's SEC filings, most directors, employees and existing shareholders are restricted for up to 180 days, and the co-founders and holders of more than 0.5% of the fully diluted shares for up to 365 days, with specified exceptions. One exception lets non-founder directors, officers, employees and consultants sell up to 10% of their holdings from the first trading day. Anthropic's amended filing puts that at up to about 315 million shares.

    A retail investor may therefore be encouraged by a broker to hold for a month while some insiders can sell on the first day. The two sets of rules come from different contracts and serve different purposes, so the comparison is not evidence of unfair treatment. It does mean the terms an investor faces depend on who they are and which platform they used.

    The UK route into US IPOs

    The Public Offers and Admissions to Trading Regulations, in force since 19 January 2026, created the public offer platform regime. It lets an authorised operator run a public offer to UK investors without a UK prospectus, which gives international issuers a way to include UK retail investors in their IPOs.

    Two operators have handled the largest deals so far. Marex ran the UK offer in SpaceX's IPO in June, and RetailBook ran Anthropic's. Distribution comes from the investment platforms. Robinhood, which launched IPO Access in the UK on 9 November, joined the Anthropic offer alongside AJ Bell, eToro, Hargreaves Lansdown, Interactive Brokers, interactive investor and Revolut.

    The infrastructure is developing quickly. The Anthropic offer shows what investors still need to find out before they apply:

    • How much of an IPO is reserved for retail investors.
    • Whether allocations are decided centrally or by each intermediary.
    • How oversubscription and scaling back are handled.
    • Whether the offer is available through an ISA or SIPP.
    • What restrictions apply to selling allocated shares.
    • Whether currency conversion, settlement and custody add costs or risks.

    For a closer look at how the brokerage model is changing, see our analysis of Robinhood's launch of IPO Access in the UK.

    Owning Anthropic without an allocation

    Many UK investors held Anthropic before the IPO, through investment trusts. Figures published by the Association of Investment Companies on 29 October list seven trusts with a stake. Scottish Mortgage first invested in August 2025 and put in $229m in total. The holding was valued at $460m at 31 July 2026, or 2.8% of the trust's assets. That one position was worth more than the $300m of shares in the entire UK retail offer. Baillie Gifford US Growth had 6.8% of its assets in Anthropic and Schiehallion 6.1%, at about 2.5 times and 3 times what they paid.

    Those gains were made before the listing. Anthropic's last private round, in May 2026, valued the company at $965bn, and the IPO price values it at about $1.5tn fully diluted. A trust is also a different investment from the shares: Anthropic is a few per cent of a wider portfolio, and trust shares trade at a discount or premium to net assets.

    Our UK pre-IPO market map compares the platforms, venues and investment structures through which UK investors can access private companies and IPOs.

    Index funds come next. MSCI has said Anthropic could enter its global indices as early as the close on 30 November, subject to its early-inclusion criteria. FTSE Russell has said it would add the shares to its Russell US indices after the close on 11 December, effective from 14 December, if they meet its fast-entry criteria, and Bloomberg reported that entry to the Nasdaq-100 could follow before the open on 21 December. Each addition depends on Anthropic passing the index provider's eligibility tests once it is trading.

    Funds that track those indices then have to buy at the market price on the day. A UK investor with a global or Nasdaq-100 tracker is therefore likely to own Anthropic within weeks, without applying for anything and at whatever the shares cost by then.

    What retail access delivered

    Anthropic's IPO shows that large international technology companies are increasingly prepared to include individual investors in deals that were historically dominated by institutions.

    It also shows the limits. A UK investor could buy at the same $83 price as a major institution and still see a larger application scaled back by a ratio that has not been published. The company decided the price, the size of the deal and how many shares went to the UK offer. The offer was also one route among several: investment trusts held Anthropic before the IPO, and index trackers are due to buy it afterwards.

    Then there is the valuation. At about $1.5tn, Anthropic comes to the public markets with high expectations already in the price. Its performance will depend on turning adoption of Claude into sustainable revenues and profits while meeting close to $900bn of purchase and lease commitments, almost all of them for computing and infrastructure.

    For private-market investors, the IPO is one stage of an investment. A place in a heavily anticipated listing does not mean that the price is attractive, that the allocation is meaningful or that the shares will perform well once trading begins.

    Other Finance view: Wider retail access to IPOs is a positive development for the UK investment market. Investors should still be wary of treating an oversubscribed IPO as an investment case in itself. The questions that matter are what they are buying, at what valuation, how many shares they receive and whether they are comfortable holding them beyond the first day of trading.

    Figures checked on 19 November 2026 against RetailBook's announcement, Anthropic's SEC filings and the press reports and index notices listed below, before the shares began trading. Averages and percentages derived from reported figures are Other Finance calculations.

    Sources

    Disclaimer: This article is for information only and is not investment advice. IPO allocations are not guaranteed, IPO shares can fall below the offer price, and you may get back less than you invest.

    Weekly newsletter

    The UK alternative investment market, weekly.

    New listings, FCA status changes, and market moves — every week.

    By subscribing, you agree to receive the weekly Other. newsletter. Unsubscribe anytime. See our Privacy Policy.